Torii Pharmaceutical Overview
- Year Founded
-
1921
- Status
-
Public
- Employees
-
645
- Stock Symbol
-
4551
- Share Price
-
$43.20
- (As of Friday Closing)
Torii Pharmaceutical General Information
Description
Torii Pharmaceutical Co Ltd is a major drug manufacturing company. The company utilizes strategic partnerships with other pharmaceutical companies in order to combine research and marketing functions. Torii's key therapeutic areas include renal diseases, hemodialysis, HIV, skin diseases, and allergens. The vast majority of the company's net mainstay product sales are derived from the renal diseases and hemodialysis operations, followed by HIV. Torii's places its strategic focus on prompt market penetration and expansion of new products as well as maximizing values of mainstay products in each priority area.
Contact Information
Website
www.torii.co.jpCorporate Office
- 3-4-1 Nihonbashi Honcho, Chuo-Ku
- Torii Nihonbashi Building
- Tokyo, 103-8439
- Japan
Corporate Office
- 3-4-1 Nihonbashi Honcho, Chuo-Ku
- Torii Nihonbashi Building
- Tokyo, 103-8439
- Japan
Torii Pharmaceutical Stock Performance
As of 11-Jul-2025, Torii Pharmaceutical’s stock price is $43.20. Its current market cap is $1.22B with 28.1M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $43.20 | $43.25 | $21.32 - $44.50 | $1.22B | 28.1M | 176K | $1.30 |
Torii Pharmaceutical Financials Summary
As of 31-Mar-2025, Torii Pharmaceutical has a trailing 12-month revenue of $404M.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 589,261 | 564,089 | 406,525 | 206,035 |
| Revenue | 404,346 | 398,981 | 388,847 | 372,048 |
| EBITDA | 44,741 | 41,029 | 45,724 | |
| Net Income | 36,430 | 33,292 | 29,315 | 30,011 |
| Total Assets | 913,438 | 895,776 | 946,125 | 1,019,593 |
| Total Debt | 0 | 2,732 | 1,730 | 3,996 |
Torii Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Torii Pharmaceutical Patents
Torii Pharmaceutical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2024094802-A | Monoclonal antibody against japanese cypress pollen antigen cha o 2 and applications thereof | Pending | 28-Dec-2022 | ||
| JP-7050734-B2 | Film preparation for sublingual allergen immunotherapy | Active | 30-Sep-2019 | ||
| JP-2021054738-A | Film preparation in sublingual allergen immunotherapy | Active | 30-Sep-2019 | ||
| JP-6982039-B2 | Monoclonal antibody against cypress pollen antigen and its use | Active | 24-Sep-2019 | ||
| JP-2021050146-A | Monoclonal antibody to hinoki cypress pollen antigen and use therefor | Active | 24-Sep-2019 |
Torii Pharmaceutical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Torii Pharmaceutical Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Torii Pharmaceutical ESG
Risk Overview
Risk Rating
Updated February, 22, 2025
35.42 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,697
Rank
Percentile
Pharmaceuticals
Industry
of 847
Rank
Percentile
Pharmaceuticals
Subindustry
of 420
Rank
Percentile
Torii Pharmaceutical FAQs
-
When was Torii Pharmaceutical founded?
Torii Pharmaceutical was founded in 1921.
-
Where is Torii Pharmaceutical headquartered?
Torii Pharmaceutical is headquartered in Tokyo, Japan.
-
What is the size of Torii Pharmaceutical?
Torii Pharmaceutical has 645 total employees.
-
What industry is Torii Pharmaceutical in?
Torii Pharmaceutical’s primary industry is Pharmaceuticals.
-
Is Torii Pharmaceutical a private or public company?
Torii Pharmaceutical is a Public company.
-
What is Torii Pharmaceutical’s stock symbol?
The ticker symbol for Torii Pharmaceutical is 4551.
-
What is the current stock price of Torii Pharmaceutical?
As of 11-Jul-2025 the stock price of Torii Pharmaceutical is $43.20.
-
What is the current market cap of Torii Pharmaceutical?
The current market capitalization of Torii Pharmaceutical is $1.22B.
-
What is Torii Pharmaceutical’s current revenue?
The trailing twelve month revenue for Torii Pharmaceutical is $404M.
-
What is Torii Pharmaceutical’s annual earnings per share (EPS)?
Torii Pharmaceutical’s EPS for 12 months was $1.30.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
